Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

Pacher, Pál, Nivorozhkin, Alex, Szabó, Csaba·2006·Pharmacological Reviews

Cited by (1,000)

Items 101–200 of 1,000

  1. Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
    David M. Maahs, Maria Luiza Caramori, David Z.I. Cherney, Andrzej T. Gałecki, Chuanyun Gao, Diana I. Jalal, Bruce A. Perkins, Rodica Pop‐Busui, Peter R Rossing, Michael S. Mauer et al. · 2013 · Current Diabetes Reports
  2. Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications
    Loubna El Harrad, Ilhame Bourais, Hasna Mohammadi, Aziz Amine · 2018 · Sensors
  3. The emerging role of the endocannabinoid system in cardiovascular disease
    Pál Pacher, Sabine Steffens · 2009 · Seminars in Immunopathology
  4. Kidney stones: an update on current pharmacological management and future directions
    Hongshi Xu, Anna L. Zisman, Fredric L. Coe, Elaine M. Worcester · 2013 · Expert Opinion on Pharmacotherapy
  5. Inhibition Studies of Bovine Xanthine Oxidase by Luteolin, Silibinin, Quercetin, and Curcumin
    James Michael Pauff, Russ Hille · 2009 · Journal of Natural Products
  6. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia–reperfusion: Therapeutic potential of mitochondrially targeted antioxidants
    Partha Mukhopadhyay, Béla Horváth, Zsuzsanna K. Zsengellér, Sándor Bátkai, Zongxian Cao, Malek Kechrid, Eileen Holovac, Katalin Erdélyi, Galin Tanchian, Lucas Liaudet et al. · 2012 · Free Radical Biology and Medicine
  7. A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania
    Rodrigo Machado‐Vieira, Jair C. Soares, Diogo Rizzato Lara, David A. Luckenbaugh, João Vicente Busnello, Getulio Marca, Angelo B.M. Cunha, Diogo Onofre Souza, Carlos A. Zarate, Flávio Pereira Kapczinski · 2008 · The Journal of Clinical Psychiatry
  8. Role of oxidative stress in chemical allergens induced skin cells activation
    Emanuela Corsini, Valentina Galbiati, Dragana Nikitovic, Aristidis Michael Tsatsakis · 2013 · Food and Chemical Toxicology
  9. Hyperuricemia, Gout, and Cardiovascular Disease: An Update
    Aryeh M. Abeles · 2015 · Current Rheumatology Reports
  10. Radiation Exposure Induces Inflammasome Pathway Activation in Immune Cells
    Veit Michael Stoecklein, Akinori Osuka, Shizu Ishikawa, Madeline R. Lederer, Lorenz Wanke-Jellinek, James Arthur Lederer · 2014 · The Journal of Immunology
  11. Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
    N. S. Rajendra, Sheila Ireland, George Casella, J. J. F. Belch, Chim Choy Lang, Allan D. Struthers · 2011 · Journal of the American College of Cardiology
  12. In vivo anti-hyperuricemic and xanthine oxidase inhibitory properties of tuna protein hydrolysates and its isolated fractions
    Weiwei He, Guowan Su, Dongxiao Sun‐Waterhouse, Geoffrey I. N. Waterhouse, Mouming Zhao, Liu Yang · 2018 · Food Chemistry
  13. The impact of xanthine oxidase (XO) on hemolytic diseases
    Heidi M. Schmidt, Eric E. Kelley, Adam C. Straub · 2018 · Redox Biology
  14. Oxidative Stress in Cell Death and Cardiovascular Diseases
    Tao Xu, Wei Ding, Xiaoyu Ji, Xiang Ao, Ying Liu, Wanpeng Yu, Jianxun Wang · 2019 · Oxidative Medicine and Cellular Longevity
  15. Tryptophan-containing milk protein-derived dipeptides inhibit xanthine oxidase
    Alice B. Nongonierma, Richard J. Fitzgerald · 2012 · Peptides
  16. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
    Jierong Luo, Dan Yan, Sisi Li, Shiming Liu, Fei Zeng, Chi Wai Cheung, Hong Liu, Michael G. Irwin, Huansen Huang, Zhengyuan Xia · 2019 · Journal of Cellular and Molecular Medicine
  17. Integrating Cellular Metabolism into a Multiscale Whole-Body Model
    Markus Krauß, Stephan Schaller, Steffen Borchers, Rolf Findeisen, Jörg Lippert, Lars Kuepfer · 2012 · PLoS Computational Biology
  18. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
    Robin Ortiz, Henning Ulrich, Carlos A. Zarate, Rodrigo Machado‐Vieira · 2014 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  19. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity
    Andrija Šmelcerović, Katarina Tomović, Žaklina Šmelcerović, Živomir Petronijević, Gordana M. Kocic, Tihomir Tomašič, Žiga Jakopin, Marko Anderluh · 2017 · European Journal of Medicinal Chemistry
  20. Salvia officinalis essential oil: Chemical analysis and evaluation of anti-enzymatic and antioxidant bioactivities
    Salma Kammoun El Euch, Dorsaf Ben Hassine, Sylvie Cazaux, Nabiha Bouzouita, Jalloul Bouajila · 2018 · South African Journal of Botany
  21. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit
    Asım Kart, Yılmaz Çiğremiş, Musa Karaman, Hasan Özen · 2009 · Experimental and Toxicologic Pathology
  22. Acceleration of Purine Degradation by Periodontal Diseases
    Virginia Monsul Barnes, Ricardo Palmier Teles, Harsh M. Trivedi, William DeVizio, Tao Xu, Matthew W. Mitchell, Michael V. Milburn, Lining Guo · 2009 · Journal of Dental Research
  23. Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study
    Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth, Jeff Kopicko, Maple M. Fung, Scott H. Adler, Nihar Bhakta, Chris M. Storgard, Scott Baumgartner, Kenneth G. Saag · 2017 · Lara D. Veeken
  24. Mutations Associated with Functional Disorder of Xanthine Oxidoreductase and Hereditary Xanthinuria in Humans
    Kimiyoshi Ichida, Yoshihiro Amaya, Ken Okamoto, Takeshi Nishino · 2012 · International Journal of Molecular Sciences
  25. Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship
    Mohd. Javed Naim, Md. Jahangir Alam, Shujauddin Ahmad, Farah Nawaz, Neelima Shrivastava, Meeta Sahu, Ozair Alam · 2017 · European Journal of Medicinal Chemistry
  26. Pharmacological Applications of Antioxidants: Lights and Shadows
    Luciano Saso, Omidreza Firuzi · 2014 · Current Drug Targets
  27. Mitochondria Oxidative Stress, Connexin43 Remodeling, and Sudden Arrhythmic Death
    Ali A. Sovari, Cody A Rutledge, Euy-Myoung Jeong, Elena V. Dolmatova, Divya Arasu, Hong Liu, Nooshin Vahdani, Lianzhi Gu, Shadi Zandieh, Lei Xiao et al. · 2013 · Circulation Arrhythmia and Electrophysiology
  28. Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
    Maria Giulia Battelli, Letizia Polito, Massimo Bortolotti, Andrea Bolognesi · 2016 · Current Medicinal Chemistry
  29. Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall
    Alzawahra, Wael F., Talukder, M. A. Hassan, Liu, Xiaoping, Samouilov, Alexandre, Zweier, Jay L. · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
  30. Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective
    Tonika Bohnert, Aarti H. Patel, Ian E. Templeton, Yuan Chen, C. Lu, George Lai, Louis Y. Leung, Susanna Tse, Heidi J. Einolf, Y.-H. Wang et al. · 2016 · Drug Metabolism and Disposition
  31. Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase
    James Michael Pauff, Hongnan Cao, Russ Hille · 2008 · Journal of Biological Chemistry
  32. Impact of allopurinol use on urate concentration and cardiovascular outcome
    Li Wei, Isla S. Mackenzie, Yang Chen, Allan D. Struthers, Thomas MacLennan MacDonald · 2010 · British Journal of Clinical Pharmacology
  33. Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases
    Raj Kumar, Gaurav Joshi, Harveen Kler, Sourav Kalra, Manpreet Kaur, Ramandeep Arya · 2017 · Medicinal Research Reviews
  34. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia
    Yi Zhang, Lijun Jin, Jinchang Liu, Wei Wang, Haiyang Yu, Jian Li, Qian Chen, Tao Wang · 2017 · Journal of Ethnopharmacology
  35. Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
    Rishab Marahatha, Saroj Basnet, Bibek Raj Bhattarai, Prakriti Budhathoki, Babita Aryal, Bikash Adhikari, Ganesh Lamichhane, Darbin Kumar Poudel, Niranjan Parajuli · 2021 · BMC Complementary Medicine and Therapies
  36. Allopurinol Acutely Increases Adenosine Triphospate Energy Delivery in Failing Human Hearts
    Glenn A. Hirsch, Paul A. Bottomley, Gary Gerstenblith, Robert George Weiss · 2012 · Journal of the American College of Cardiology
  37. Xanthine oxidase inhibitors: a patent survey
    Raj Kumar, Darpan, Sahil Sharma, Rajveer Singh · 2011 · Expert Opinion on Therapeutic Patents
  38. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion
    Moon, Kwan–Hoon, Hood, Brian L., Mukhopadhyay, Partha, Rajesh, Mohanraj, Abdelmegeed, Mohamed A., Kwon, Yong–Il, Conrads, Thomas P., Veenstra, Timothy D., Song, Byoung–Joon, Pacher, Pal · 2008 · Gastroenterology
  39. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease
    Susana Cadenas, Julián Aragonés, Manuel O. Landázuri · 2010 · Cardiovascular Research
  40. Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour
    Sinead M. Gibney, Eimear M. Fagan, Ann‐Marie Waldron, Jordan O’Byrne, Thomas J. Connor, Andrew Harkin · 2014 · The International Journal of Neuropsychopharmacology
  41. Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout
    Takeshi Nishino, Ken Okamoto · 2014 · JBIC Journal of Biological Inorganic Chemistry
  42. Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
    Miles Trupp, Hongjie Zhu, William R. Wikoff, Rebecca Baillie, Zhao‐Bang Zeng, Peter D. Karp, Oliver Fiehn, Ronald M. Krauss, Rima F Kaddurah-Daouk · 2012 · PLoS ONE
  43. Olea europaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase
    Jörg Flemmig, Kenny Kuchta, Jürgen Arnhold, Hans-Wilhelm Rauwald · 2010 · Phytomedicine
  44. Cytotoxicity of paraquat in microglial cells: Involvement of PKCδ- and ERK1/2-dependent NADPH oxidase
    Rebecca L. Miller, Grace Y. Sun, Albert Y. Sun · 2007 · Brain Research
  45. Xanthine oxidoreductase in respiratory and cardiovascular disorders
    Adel R. Boueiz, Mahendra Damarla, Paul M. Hassoun · 2008 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  46. An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)
    Ritu Ojha, Jagjeet Singh, Anu Ojha, Harbinder Singh, Sahil Sharma, Kunal Nepali · 2016 · Expert Opinion on Therapeutic Patents
  47. Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure‐Based Drug Design
    Giuseppe Luna, Anton V. Dolzhenko, Ricardo L. Mancera · 2019 · ChemMedChem
  48. Bioactivity analysis of lemongrass (Cymbopogan citratus) essential oil.
    Mohamed Elwathig Saeed Mirghani, Y. Liyana, Parveen Jamal · 2012 · The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
  49. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics
    Margherita Strolin Benedetti, Rhys Whomsley, Eugène Baltes · 2006 · Expert Opinion on Drug Metabolism & Toxicology
  50. Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC–ESI MS/MS and their xanthine oxidase inhibition
    Dae Wook Kim, Marcus J. C. Long, Heung Joo Yuk, Yan Wang, Yeong Hun Song, Seong Hun Jeong, Ki Hun Park · 2013 · Food Chemistry
  51. Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage
    Fernando E. García‐Arroyo, Guillermo Gonzaga, Itzel Muñoz-Jiménez, Mónica G. Blas-Marron, Octaviano Silverio, Edilia Tapia, Virgilia Soto, Natarajan Ranganathan, Pari Ranganathan, Usha Vyas et al. · 2018 · PLoS ONE
  52. Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers
    Emily Hofmann, Jonathan Webster, Thuy Do, Reid Kline, Lindsey Snider, Quintin Hauser, Grace Higginbottom, Austin Campbell, Lili Ma, Stefan Paula · 2015 · Bioorganic & Medicinal Chemistry
  53. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy
    Tejasvi Chaudhari, William Leo McGuire · 2008 · Cochrane Database of Systematic Reviews
  54. 1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
    Felicia Phei Lin Lim, Anton V. Dolzhenko · 2014 · European Journal of Medicinal Chemistry
  55. Nitric Oxide-cGMP Signaling in Hypertension
    Ehsan Ataei Ataabadi, Keivan Golshiri, Annika A. Jüttner, Guido Krenning, A.H. Jan Danser, Anton J.M. Roks · 2020 · Hypertension
  56. In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb.
    Muthuswamy Umamaheswari, Kuppuswamy Asokkumar, A.T. Sivashanmugam, A. Remyaraju, Varadharajan Subhadradevi, T. K. Ravi · 2009 · Journal of Ethnopharmacology
  57. Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling
    Amit Agarwal, Avik Banerjee, Uttam Chand Banerjee · 2011 · Critical Reviews in Biotechnology
  58. Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout
    James E. Frampton · 2015 · Drugs
  59. Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population
    Masato Furuhashi, Megumi Matsumoto, Marenao Tanaka, Norihito Moniwa, Takayo Murase, Takashi Nakamura, Hirofumi Ohnishi, Shigeyuki Saitoh, Kazuaki Shimamoto, Tetsuji Miura · 2018 · Circulation Journal
  60. Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury
    Borami Shin, Douglas B. Cowan, Sitaram M. Emani, Pedro J. del Nido, James D. McCully · 2017 · Advances in experimental medicine and biology
  61. Substrate Orientation in Xanthine Oxidase
    James Michael Pauff, Jinjin Zhang, Charles E. Bell, Russ Hille · 2007 · Journal of Biological Chemistry
  62. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
    Marilisa Bove, Arrigo F.G. Cicero, Maddalena Veronesi, Claudio Borghi · 2017 · Vascular Health and Risk Management
  63. Identification and quantification of a major anti-oxidant and anti-inflammatory phenolic compound found in basil, lemon thyme, mint, oregano, rosemary, sage, and thyme
    Park, Jae B. · 2011 · International Journal of Food Sciences and Nutrition
  64. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors
    Shaolei Chen, Tingjian Zhang, Jian Wang, Fangyang Wang, Handong Niu, Chunfu Wu, Shaojie Wang · 2015 · European Journal of Medicinal Chemistry
  65. Molybdenum in Human Health and Disease
    Günter Schwarz, Abdel Ali Belaidi · 2013 · Metal ions in life sciences
  66. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors
    Jeong Uk Song, Sung Pil Choi, Tae Hun Kim, Cheol-Kyu Jung, Joo‐Youn Lee, Sang‐Hun Jung, Geun Tae Kim · 2015 · Bioorganic & Medicinal Chemistry Letters
  67. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy
    Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, Bani Mukhopadhyay, Vivek Patel, György Haskó, Csaba Szabó, Jon G. Mabley, Lucas Liaudet, Pál Pacher · 2008 · Journal of Cellular and Molecular Medicine
  68. Anti-hyperuricemic and anti-gouty arthritis activities of polysaccharide purified from Lonicera japonica in model rats
    Qiuxuan Yang, Qilong Wang, Wenwen Deng, Congyong Sun, Qiuyu Wei, Michael Adu‐Frimpong, Jixiang Shi, Jiangnan Yu, Ximing Xu · 2018 · International Journal of Biological Macromolecules
  69. Small-Molecule Inhibitors of Reactive Oxygen Species Production
    Elisa Sassetti, Mads H. Clausen, Luca Laraia · 2021 · Journal of Medicinal Chemistry
  70. Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase
    Chrysoula Spanou, Aristidis S. Veskoukis, Thalia Kerasioti, Maria Kontou, Apostolis Angelis, Nektarios Aligiannis, Alexios‐Léandros Skaltsounis, Demetrios Kouretas · 2012 · PLoS ONE
  71. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk
    Claudio Borghi, Andrzej Tykarski, Krystyna Widecka, Krzysztof Jerzy Filipiak, Justyna Domienik‐Karłowicz, Katarzyna Kostka-Jeziorny, Andrea Varga, Milosz Jaroslaw Jaguszewski, Krzysztof Narkiewicz, Giuseppe Mancia · 2018 · Cardiology Journal
  72. Encapsulation of allopurinol by glucose cross-linked gelatin/zein nanofibers: Characterization and release behavior
    Lingli Deng, Yang Li, Fengqin Feng, Di Wu, Hui Zhang · 2019 · Food Hydrocolloids
  73. Inhibition of chrysin on xanthine oxidase activity and its inhibition mechanism
    Suyun Lin, Guowen Zhang, Yijing Liao, Junhui Pan · 2015 · International Journal of Biological Macromolecules
  74. Design and Synthesis of Aza‐Flavones as a New Class of Xanthine Oxidase Inhibitors
    Rajni Dhiman, Sahil Sharma, Gagandip Singh, Kunal Nepali, Preet Mohinder Singh Bedi · 2012 · Archiv der Pharmazie
  75. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
    Yoichiro Otaki, Tetsu Watanabe, Daisuke Kinoshita, Miyuki Yokoyama, Tetsuya Takahashi, Taku Toshima, Takayuki Sugai, Takayo Murase, Takashi Nakamura, Satoshi Nishiyama et al. · 2016 · International Journal of Cardiology
  76. Xanthine oxidase is one of the major sources of superoxide anion radicals in blood after reperfusion in rats with forebrain ischemia/reperfusion
    Takeru Ono, Ryosuke Tsuruta, Motoki Fujita, Hiromi Shinagawa Aki, Satoshi Kutsuna, Yoshikatsu Kawamura, Jun Wakatsuki, Tetsuya Aoki, Chihiro Kobayashi, Shunji Kasaoka et al. · 2009 · Brain Research
  77. A Combined QM/MM Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism
    Sebastian Metz, Walter Thiel · 2009 · Journal of the American Chemical Society
  78. Screening of a library of 4-aryl/heteroaryl-4H-fused pyrans for xanthine oxidase inhibition: synthesis, biological evaluation and docking studies
    Ramandeep Kaur, Fatima Naaz, Sahil Sharma, Samir Mehndiratta, Manish Gupta, Preet Mohinder Singh Bedi, Kunal Nepali · 2015 · Medicinal Chemistry Research
  79. Bilirubin Prevents Atherosclerotic Lesion Formation in Low‐Density Lipoprotein Receptor‐Deficient Mice by Inhibiting Endothelial VCAM‐1 and ICAM‐1 Signaling
    Megan E. Vogel, Gila Idelman, Eddy S. Konaniah, Stephen D. Zucker · 2017 · Journal of the American Heart Association
  80. Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
    Kurt W. Prins, Thenappan Thenappan, Ε. Kenneth Weir, Rajat Kalra, MARC R. PRITZKER, Stephen L. Archer · 2018 · Journal of the American Heart Association
  81. Oxidants and Redox Signaling in Acute Lung Injury
    J. Vidya Sarma, Peter A. Ward · 2011 · Comprehensive physiology
  82. Antioxidant Action of Carnitine: Molecular Mechanisms and Practical Applications
    Peter F. Surai · 2015
  83. Emerging Role of Flavonoids as the Treatment of Depression
    Arzoo Singh Pannu, Prabodh Chander Sharma, Vijay Kumar Thakur, Ramesh K. Goyal · 2021 · Biomolecules
  84. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout
    Jian-Ming Lü, Qizhi Cathy Yao, Changyi Chen · 2013 · Biochemical Pharmacology
  85. Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice
    Takashi Nakamura, Takayo Murase, Mai Nampei, Nobutaka Morimoto, Naoki Ashizawa, Takashi Iwanaga, Ryusuke Sakamoto · 2016 · European Journal of Pharmacology
  86. Anti‐nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1adenosine receptors
    AP Schmidt, Ana Elisa Böhmer, Catiele Antunes, Cristhine Schallenberger, LO Porciúncula, Elaine Elisabetsky, DR Lara, Diogo Onofre Souza · 2008 · British Journal of Pharmacology
  87. Enhanced XOR activity in eNOS-deficient mice
    Maria Peleli, Christa Zollbrecht, Marcelo Freitas Montenegro, Michael P. Hezel, Jianghong Zhong, Erik Persson, Rikard Holmdahl, Eddie Weitzberg, Jon O. Lundberg, Mattias Carlström · 2016 · Free Radical Biology and Medicine
  88. Allopurinol as a Cardiovascular Drug
    Anita A. Kelkar, Allen Kuo, William H. Frishman · 2011 · Cardiology in Review
  89. Xanthine Oxidoreductase Depletion Induces Renal Interstitial Fibrosis Through Aberrant Lipid and Purine Accumulation in Renal Tubules
    Toshio Ohtsubo, Kiyoshi Matsumura, Kanae Sakagami, Koji Fujii, Kazuhiko Tsuruya, Hideko Noguchi, Ilsa I. Rovira, Toren Finkel, Mitsuo Iida · 2009 · Hypertension
  90. Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection
    Lara Testai · 2015 · Life Sciences
  91. Bioactive polyphenols in Ximenia americana and the traditional use among Malian healers
    Nhat Hao Tran Le, Karl Egil Malterud, Drissa Diallo, Berit Smestad Paulsen, Cecilie Sogn Nergård, Helle Wangensteen · 2011 · Journal of Ethnopharmacology
  92. Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
    Laura E. Via, Radojka M. Savić, Danielle M. Weiner, Matthew D. Zimmerman, Brendan Prideaux, Scott M. Irwin, Eddie Lyon, Paul E. O’Brien, Pooja Gopal, Seok‐Yong Eum et al. · 2015 · ACS Infectious Diseases
  93. The Chemistry of Neurodegeneration: Kinetic Data and Their Implications
    Matic Pavlin, Matej Repič, Robert Vianello, Janez Mavri · 2015 · Molecular Neurobiology
  94. Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study
    María Lorenza Muiesan, Massimo Salvetti, Agostino Virdis, Stefano Masi, Edoardo Casiglia, Valérie Tikhonoff, Carlo Maria Barbagallo, Michele Bombelli, Arrigo F.G. Cicero, Massimo Círillo et al. · 2020 · Journal of Hypertension
  95. Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs
    Lara Testai, Simona Rapposelli, Alma Martelli, Maria Cristina Breschi, Vincenzo Calderone · 2014 · Medicinal Research Reviews
  96. Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal
    Tuhina Neogi, George Casella, Sushma Rekhraj, Allan D. Struthers, Hyon K. Choi, Robert A. Terkeltaub · 2011 · Arthritis & Rheumatism
  97. Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters
    George Diallinas · 2014 · Frontiers in Pharmacology
  98. The Antioxidant and Xanthine Oxidase Inhibitory Activity of Plumeria rubra Flowers
    S. Isa, Abdulwali Ablat, Jamaludin Mohamad · 2018 · Molecules
  99. Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
    Tao Han Lee, Jia‐Jin Chen, Chao‐Yi Wu, Chih‐Wei Yang, Huang‐Yu Yang · 2021 · Diagnostics
  100. Concordance between antioxidant activities and flavonol contents in different extracts and fractions of Cuscuta chinensis
    Feng‐Lin Yen, Tzu-Hui Wu, Liang Lin, Thau‐Ming Cham, Chun‐Ching Lin · 2007 · Food Chemistry